SummaryGlenmark Pharmaceuticals has recalled 26,928 packs of oral contraceptive pills, including Viorele and Desogestrel-Ethinyl Estradiol, in the US due to failed impurity and degradation specifications, the USFDA reported. The Class II recall, initiated on September 3, 2025, indicates potential temporary health effects. Dr Reddy’s Laboratories also recalled a muscle relaxant injection.